Latest news with #ArticoreGroup
AU Financial Review
3 days ago
- Business
- AU Financial Review
Star chair Anne Ward's other sharemarket dumpster fire
Star Entertainment chairwoman Anne Ward attended 45 board meetings (of a possible 46) of the distressed casino operator in the 2024 financial year. It's surely one of the busiest director schedules on the ASX. Necessitated by Star Entertainment being a dumpster fire (which might be unfair to dumpsters and/or fires). Less known is that Ward is also chairwoman of the ASX-listed Articore Group, the ecommerce operator of Redbubble. She joined as a director in 2018.
Yahoo
17-04-2025
- Business
- Yahoo
We Think Articore Group (ASX:ATG) Can Afford To Drive Business Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. Given this risk, we thought we'd take a look at whether Articore Group (ASX:ATG) shareholders should be worried about its cash burn. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth (also called its negative free cash flow). First, we'll determine its cash runway by comparing its cash burn with its cash reserves. We've discovered 2 warning signs about Articore Group. View them for free. A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. In December 2024, Articore Group had AU$71m in cash, and was debt-free. Looking at the last year, the company burnt through AU$15m. So it had a cash runway of about 4.8 years from December 2024. Importantly, though, analysts think that Articore Group will reach cashflow breakeven before then. In that case, it may never reach the end of its cash runway. Depicted below, you can see how its cash holdings have changed over time. See our latest analysis for Articore Group One thing for shareholders to keep front in mind is that Articore Group increased its cash burn by 223% in the last twelve months. As if that's not bad enough, the operating revenue also dropped by 11%, making us very wary indeed. In light of the above-mentioned, we're pretty wary of the trajectory the company seems to be on. Clearly, however, the crucial factor is whether the company will grow its business going forward. So you might want to take a peek at how much the company is expected to grow in the next few years. Articore Group seems to be in a fairly good position, in terms of cash burn, but we still think it's worthwhile considering how easily it could raise more money if it wanted to. Generally speaking, a listed business can raise new cash through issuing shares or taking on debt. One of the main advantages held by publicly listed companies is that they can sell shares to investors to raise cash and fund growth. By comparing a company's annual cash burn to its total market capitalisation, we can estimate roughly how many shares it would have to issue in order to run the company for another year (at the same burn rate). Since it has a market capitalisation of AU$42m, Articore Group's AU$15m in cash burn equates to about 35% of its market value. That's not insignificant, and if the company had to sell enough shares to fund another year's growth at the current share price, you'd likely witness fairly costly dilution. It may already be apparent to you that we're relatively comfortable with the way Articore Group is burning through its cash. In particular, we think its cash runway stands out as evidence that the company is well on top of its spending. Although we do find its increasing cash burn to be a bit of a negative, once we consider the other metrics mentioned in this article together, the overall picture is one we are comfortable with. There's no doubt that shareholders can take a lot of heart from the fact that analysts are forecasting it will reach breakeven before too long. Looking at all the measures in this article, together, we're not worried about its rate of cash burn; the company seems well on top of its medium-term spending needs. On another note, Articore Group has 2 warning signs (and 1 which doesn't sit too well with us) we think you should know about. Of course Articore Group may not be the best stock to buy. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
07-03-2025
- Business
- Yahoo
Insider Spends AU$162k Buying More Shares In Articore Group
Investors who take an interest in Articore Group Limited (ASX:ATG) should definitely note that the Co-Founder, Martin Hosking, recently paid AU$0.26 per share to buy AU$162k worth of the stock. While that's a very decent purchase to our minds, it was proportionally a bit modest, boosting their holding by just 1.5%. Check out our latest analysis for Articore Group Notably, that recent purchase by Co-Founder Martin Hosking was not the only time they bought Articore Group shares this year. They previously made an even bigger purchase of AU$305k worth of shares at a price of AU$0.35 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being AU$0.24). It's very possible they regret the purchase, but it's more likely they are bullish about the company. To us, it's very important to consider the price insiders pay for shares. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels. While Articore Group insiders bought shares during the last year, they didn't sell. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below! Articore Group is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket. For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 28% of Articore Group shares, worth about AU$19m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment. It's certainly positive to see the recent insider purchase. And the longer term insider transactions also give us confidence. But we don't feel the same about the fact the company is making losses. When combined with notable insider ownership, these factors suggest Articore Group insiders are well aligned, and that they may think the share price is too low. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. For example - Articore Group has 2 warning signs we think you should be aware of. If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
10-02-2025
- Business
- Yahoo
February 2025's ASX Penny Stocks With Growth Potential
The Australian stock market has faced a slight downturn, with the ASX200 down 0.36% amid concerns over new tariffs on aluminium and steel imposed by the Trump administration. Despite these challenges, certain sectors like Utilities and Health Care have shown resilience, highlighting opportunities for investors to explore undervalued segments of the market. Penny stocks, often representing smaller or newer companies, remain a relevant investment area; when backed by strong financials and fundamentals, they can offer growth potential at lower price points. Name Share Price Market Cap Financial Health Rating Embark Early Education (ASX:EVO) A$0.77 A$141.28M ★★★★☆☆ LaserBond (ASX:LBL) A$0.57 A$66.88M ★★★★★★ EZZ Life Science Holdings (ASX:EZZ) A$1.90 A$89.63M ★★★★★★ Austin Engineering (ASX:ANG) A$0.495 A$306.97M ★★★★★☆ MaxiPARTS (ASX:MXI) A$1.92 A$106.21M ★★★★★★ Dusk Group (ASX:DSK) A$1.065 A$66.32M ★★★★★★ Helloworld Travel (ASX:HLO) A$2.04 A$332.15M ★★★★★★ SHAPE Australia (ASX:SHA) A$3.00 A$248.73M ★★★★★★ IVE Group (ASX:IGL) A$2.19 A$339.21M ★★★★☆☆ Vita Life Sciences (ASX:VLS) A$1.90 A$105.71M ★★★★★★ Click here to see the full list of 1,031 stocks from our ASX Penny Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Articore Group Limited operates as an online marketplace for art and design products across Australia, the United States, the United Kingdom, and internationally, with a market cap of A$68.15 million. Operations: The company generates revenue of A$492.99 million from its Redbubble and Teepublic marketplaces. Market Cap: A$68.15M Articore Group Limited, with a market cap of A$68.15 million, operates as an online marketplace generating A$492.99 million in revenue from its Redbubble and Teepublic platforms. Despite being debt-free and having a sufficient cash runway for over three years, the company remains unprofitable with increasing losses over the past five years at 20.5% annually. Its short-term assets do not cover short-term liabilities, reflecting potential liquidity challenges. The management team is experienced but the board is relatively new, which may impact strategic stability amid recent executive changes like Ben Heap's temporary leave from the board. Click to explore a detailed breakdown of our findings in Articore Group's financial health report. Examine Articore Group's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Imugene Limited is a clinical-stage immuno-oncology company based in Australia that focuses on developing immunotherapies to activate the immune system for treating and eradicating tumors, with a market cap of approximately A$275.93 million. Operations: The company's revenue segment is focused on the research, development, and commercialisation of health technologies, generating A$4.97 million. Market Cap: A$275.93M Imugene Limited, with a market cap of A$275.93 million, remains pre-revenue and unprofitable, with losses increasing at 54.1% annually over the past five years. Despite this, the company is debt-free and has short-term assets of A$113 million exceeding both short-term liabilities (A$29.3 million) and long-term liabilities (A$3.8 million), indicating financial stability in covering obligations. Recent capital raises through private placements and convertible notes have bolstered its cash runway to approximately 11 months based on free cash flow estimates, providing a buffer to continue its research activities while navigating profitability challenges amid management turnover. Get an in-depth perspective on Imugene's performance by reading our balance sheet health report here. Gain insights into Imugene's outlook and expected performance with our report on the company's earnings estimates. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: OM Holdings Limited is an investment holding company involved in the mining, smelting, trading, and marketing of manganese ores and ferroalloys globally, with a market cap of A$267.51 million. Operations: The company's revenue primarily comes from its Smelting segment, which generated $441.70 million, and its Marketing and Trading segment, contributing $631.02 million. Market Cap: A$267.51M OM Holdings Limited, with a market cap of A$267.51 million, is trading significantly below its estimated fair value and maintains a satisfactory net debt to equity ratio of 34.5%. The company's short-term assets exceed both long-term liabilities and short-term liabilities, indicating strong liquidity. However, interest payments are not well covered by EBIT, suggesting potential financial strain if earnings do not improve. Recent reports show stable production and sales figures for ferrosilicon and manganese alloys in 2024, with production guidance for 2025 set between 170,000-190,000 tonnes for ferrosilicon and 270,000-300,000 tonnes for manganese alloys. Click here to discover the nuances of OM Holdings with our detailed analytical financial health report. Review our growth performance report to gain insights into OM Holdings' future. Take a closer look at our ASX Penny Stocks list of 1,031 companies by clicking here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ATG ASX:IMU and ASX:OMH. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
10-02-2025
- Business
- Yahoo
February 2025's ASX Penny Stocks With Growth Potential
The Australian stock market has faced a slight downturn, with the ASX200 down 0.36% amid concerns over new tariffs on aluminium and steel imposed by the Trump administration. Despite these challenges, certain sectors like Utilities and Health Care have shown resilience, highlighting opportunities for investors to explore undervalued segments of the market. Penny stocks, often representing smaller or newer companies, remain a relevant investment area; when backed by strong financials and fundamentals, they can offer growth potential at lower price points. Name Share Price Market Cap Financial Health Rating Embark Early Education (ASX:EVO) A$0.77 A$141.28M ★★★★☆☆ LaserBond (ASX:LBL) A$0.57 A$66.88M ★★★★★★ EZZ Life Science Holdings (ASX:EZZ) A$1.90 A$89.63M ★★★★★★ Austin Engineering (ASX:ANG) A$0.495 A$306.97M ★★★★★☆ MaxiPARTS (ASX:MXI) A$1.92 A$106.21M ★★★★★★ Dusk Group (ASX:DSK) A$1.065 A$66.32M ★★★★★★ Helloworld Travel (ASX:HLO) A$2.04 A$332.15M ★★★★★★ SHAPE Australia (ASX:SHA) A$3.00 A$248.73M ★★★★★★ IVE Group (ASX:IGL) A$2.19 A$339.21M ★★★★☆☆ Vita Life Sciences (ASX:VLS) A$1.90 A$105.71M ★★★★★★ Click here to see the full list of 1,031 stocks from our ASX Penny Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Articore Group Limited operates as an online marketplace for art and design products across Australia, the United States, the United Kingdom, and internationally, with a market cap of A$68.15 million. Operations: The company generates revenue of A$492.99 million from its Redbubble and Teepublic marketplaces. Market Cap: A$68.15M Articore Group Limited, with a market cap of A$68.15 million, operates as an online marketplace generating A$492.99 million in revenue from its Redbubble and Teepublic platforms. Despite being debt-free and having a sufficient cash runway for over three years, the company remains unprofitable with increasing losses over the past five years at 20.5% annually. Its short-term assets do not cover short-term liabilities, reflecting potential liquidity challenges. The management team is experienced but the board is relatively new, which may impact strategic stability amid recent executive changes like Ben Heap's temporary leave from the board. Click to explore a detailed breakdown of our findings in Articore Group's financial health report. Examine Articore Group's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Imugene Limited is a clinical-stage immuno-oncology company based in Australia that focuses on developing immunotherapies to activate the immune system for treating and eradicating tumors, with a market cap of approximately A$275.93 million. Operations: The company's revenue segment is focused on the research, development, and commercialisation of health technologies, generating A$4.97 million. Market Cap: A$275.93M Imugene Limited, with a market cap of A$275.93 million, remains pre-revenue and unprofitable, with losses increasing at 54.1% annually over the past five years. Despite this, the company is debt-free and has short-term assets of A$113 million exceeding both short-term liabilities (A$29.3 million) and long-term liabilities (A$3.8 million), indicating financial stability in covering obligations. Recent capital raises through private placements and convertible notes have bolstered its cash runway to approximately 11 months based on free cash flow estimates, providing a buffer to continue its research activities while navigating profitability challenges amid management turnover. Get an in-depth perspective on Imugene's performance by reading our balance sheet health report here. Gain insights into Imugene's outlook and expected performance with our report on the company's earnings estimates. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: OM Holdings Limited is an investment holding company involved in the mining, smelting, trading, and marketing of manganese ores and ferroalloys globally, with a market cap of A$267.51 million. Operations: The company's revenue primarily comes from its Smelting segment, which generated $441.70 million, and its Marketing and Trading segment, contributing $631.02 million. Market Cap: A$267.51M OM Holdings Limited, with a market cap of A$267.51 million, is trading significantly below its estimated fair value and maintains a satisfactory net debt to equity ratio of 34.5%. The company's short-term assets exceed both long-term liabilities and short-term liabilities, indicating strong liquidity. However, interest payments are not well covered by EBIT, suggesting potential financial strain if earnings do not improve. Recent reports show stable production and sales figures for ferrosilicon and manganese alloys in 2024, with production guidance for 2025 set between 170,000-190,000 tonnes for ferrosilicon and 270,000-300,000 tonnes for manganese alloys. Click here to discover the nuances of OM Holdings with our detailed analytical financial health report. Review our growth performance report to gain insights into OM Holdings' future. Take a closer look at our ASX Penny Stocks list of 1,031 companies by clicking here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ATG ASX:IMU and ASX:OMH. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
